IGKC	gene symbol: IGKC. Functionality: antigen binding, adaptive immune response, b cell receptor signaling, immunoglobulin complex involvement. Phenotype: her2-positive breast cancer association, immune response modulation. 
TMSB10	gene symbol: TMSB10. Functionality: protein binding, actin filament organization, actin monomer binding, regulation of cell migration, actin monomer sequestering. Phenotype: involvement in her2-positive breast cancer due to altered cell migration and cytoskeletal dynamics 
ERBB2	gene symbol: ERBB2. Functionality: cell signaling, growth factor binding, receptor activity, protein binding, kinase activity, phosphorylation, signal transduction, chromatin remodeling, receptor complex formation. Phenotype: her2-positive breast cancer, enhanced cell proliferation, positive regulation of cell growth, angiogenesis, epithelial cell proliferation, negative regulation of apoptosis, neurogenesis, developmental processes. 
IGHG3	gene symbol: IGHG3. Functionality: involved in immune response, b cell receptor signaling, complement activation, antigen binding, antibacterial response. Phenotype: associated with adaptive immunity, extracellular localization, igg immunoglobulin complex, receptor binding. 
IGLC2	gene symbol: IGLC2. Functionality: antigen binding, igg complex component, immune response mediator. Phenotype: enhanced immune response, potentially involved in her2-positive breast cancer 
IGHA1	gene symbol: HER2. Functionality: encodes receptor tyrosine kinase, cell growth, differentiation, signal transduction. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis, resistance to therapy. 
GAPDH	gene symbol: HER2. Functionality: receptor tyrosine kinase activity, cell growth regulation, signal transduction, dimerization for activation. Phenotype: increased cell proliferation, enhanced tumor growth, aggressive breast cancer, poor prognosis. 
ACTB	gene symbol: ERBB2. Functionality: protein tyrosine kinase activity, receptor signaling, cell proliferation, differentiation. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis, therapeutic target. 
IGLC3	gene symbol: IGLC3. Functionality: involved in adaptive immune response, b cell receptor signaling, antigen binding; part of igg, igd, ige, iga, igm immunoglobulin complexes. Phenotype: her2-positive breast cancer exhibits altered immune response and signaling pathway activity; potential changes in immunoglobulin-mediated responses. 
IGHM	gene symbol: HER2. Functionality: her2 is a receptor tyrosine kinase involved in cell growth, differentiation, and repair. it is part of the erbb family and participates in signal transduction pathways. overexpression can lead to uncontrolled cell proliferation. Phenotype: her2-positive breast cancer is characterized by aggressive tumor growth, increased recurrence risk, and poor prognosis. it is more likely to spread and is less responsive to hormonal treatment. 
SERF2	gene symbol: SERF2. Functionality: involved in protein destabilization and aggregation processes. Phenotype: linked to her2-positive breast cancer progression. 
PSMB3	gene symbol: PSMB3. Functionality: protein binding, proteasome-mediated ubiquitin-dependent protein catabolic process, active in nucleus, cytoplasm, cytosol, extracellular exosome, part of proteasome complex. Phenotype: overexpression linked to her2-positive breast cancer, affects protein degradation, contributes to tumor progression. 
PFN1	gene symbol: PFN1. Functionality: actin binding, rna binding, nucleotide exchange, protein binding, cadherin binding, synaptic transmission modulation. Phenotype: neural tube closure, epithelial cell migration, actin cytoskeleton organization, synapse maturation, postsynaptic actin modification 
ACTG1	gene symbol: ACTG1. Functionality: cytoskeletal structure, protein binding, angiogenesis, cell migration, gene expression regulation, synaptic vesicle endocytosis, stress fiber assembly, focal adhesion, wound healing, tight junction, blood-brain barrier maintenance, platelet aggregation, axonogenesis. Phenotype: her2-positive breast cancer progression, metastasis, altered cell motility, enhanced angiogenesis, disrupted cell junctions. 
KRT19	gene symbol: KRT19. Functionality: structural constituent of cytoskeleton, protein binding, involved in notch signaling, response to estrogen, sarcomere organization, cell differentiation, intermediate filament organization. Phenotype: expressed in her2-positive breast cancer, influences cell differentiation, affects structural integrity, involved in signal transduction, related to tumor progression. 
RACK1	gene symbol: RACK1. Functionality: protein binding, kinase binding, receptor binding, enzyme activator, ion channel inhibitor, translation regulation, apoptosis regulation, signaling adaptor, protein phosphorylation regulation, protein localization regulation, cell cycle regulation. Phenotype: her2-positive breast cancer, affects cell migration, growth, apoptosis, protein ubiquitination, cell division, response to growth factors. 
MUCL1	gene symbol: MUCL1. Functionality: protein binding, localization to extracellular region, golgi lumen, plasma membrane. Phenotype: associated with her2-positive breast cancer 
CISD3	gene symbol: CISD3. Functionality: metal ion binding, 2fe-2s cluster binding, protein maturation. Phenotype: her2-positive breast cancer, mitochondrial involvement 
APOE	gene symbol: HER2. Functionality: receptor tyrosine kinase, signal transduction, cell growth regulation, proliferation control. Phenotype: breast cancer, aggressive tumor growth, poor prognosis, targeted therapy potential 
MIEN1	gene symbol: MIEN1. Functionality: protein binding, regulation of apoptosis, cell migration, filopodium assembly. Phenotype: her2-positive breast cancer progression, metastasis 
SSR4	gene symbol: SSR4. Functionality: part of sec61 translocon complex, involved in protein translocation across endoplasmic reticulum membrane. Phenotype: implications in her2-positive breast cancer, affecting protein processing and cell signaling. 
CALR	gene symbol: CALR. Functionality: calcium-binding chaperone, protein folding, transcription regulation, cell cycle regulation, immune response. Phenotype: her2-positive breast cancer, cell proliferation, apoptosis regulation, extracellular matrix interaction. 
PSAP	gene symbol: PSAP. Functionality: protease binding, protein binding, phospholipid binding, enzyme activator, homodimerization, scaffold binding, ganglioside binding, sphingolipid metabolism, lysosomal transport, autophagy regulation, beta-galactosidase regulation, adenylate cyclase inhibition, prostate growth, lipid metabolism regulation. Phenotype: her2-positive breast cancer, prostate gland development, epithelial cell differentiation, lipid metabolic disorders, lysosomal storage diseases. 
CTSD	gene symbol: CTSD. Functionality: aspartic-type peptidase activity, endopeptidase activity, protein binding, proteolysis, antigen processing, autophagosome assembly, insulin receptor recycling, lipoprotein catabolism, apoptosis regulation. Phenotype: her2-positive breast cancer association, influences apoptosis, impacts insulin processing, alters protein localization, affects antigen presentation, modulates matrix interactions, influences cancer progression. 
FTL	gene symbol: FTL. Functionality: iron ion binding, protein binding, identical protein binding, iron ion transport, intracellular iron ion homeostasis, ferric and ferrous iron binding. Phenotype: associated with iron metabolism, potential dysregulation in cancer, related to her2-positive breast cancer 
FTH1	gene symbol: FTH1. Functionality: ferroxidase activity, iron ion binding, protein binding, iron sequestering, homeostasis, immune response, negative regulation of proliferation and ferroptosis. Phenotype: involvement in her2-positive breast cancer, iron metabolism, cell proliferation regulation, ferroptosis inhibition, immune response modulation, affects tumor growth. 
TPT1	gene symbol: ERBB2. Functionality: encodes a receptor tyrosine kinase, involved in cell growth and differentiation, signal transduction. Phenotype: overexpression linked to her2-positive breast cancer, associated with aggressive tumor growth, poor prognosis 
PTPRF	gene symbol: PTPRF. Functionality: phosphoprotein phosphatase, protein tyrosine phosphatase, transmembrane receptor phosphatase, heparin and proteoglycan binding, complex binding, cell adhesion, chromatin remodeling, signaling pathway, migration, axon regeneration, receptor regulation. Phenotype: her2-positive breast cancer association, impacts cell adhesion and migration, affects axon regeneration and nervous system development, influences signal transduction processes. 
UBA52	gene symbol: UBA52. Functionality: ribosomal structure, protein binding, translation, protein modification, ubiquitination, protein tagging. Phenotype: in her2-positive breast cancer, uba52 may influence tumor growth through its roles in protein synthesis, modification, and degradation 
P4HB	gene symbol: P4HB. Functionality: peptidyl-proline hydroxylation, protein disulfide isomerase, rna and actin binding, integrin binding, protein folding, thiol oxidase activity. Phenotype: regulates cell adhesion, viral entry, oxidative stress response, interleukin signaling, and hypoxia response. involved in her2-positive breast cancer progression. 
BEST1	gene symbol: BEST1. Functionality: chloride channel activity, calcium-gated, bicarbonate transport, protein binding, ligand-gated channel, visual perception, synaptic plasticity, ion transport. Phenotype: her2-positive breast cancer, altered chloride transport, visual perception issues, synaptic transmission abnormalities 
HLA-B	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth, differentiation, survival, ligand binding, dimerization, signaling pathways. Phenotype: breast cancer, overexpression, tumor aggressiveness, poor prognosis, targeted therapy response. 
FAU	gene symbol: FAU. Functionality: rna binding, ribosomal assembly, protein binding, translation, immune response, ubiquitination, protein tagging. Phenotype: her2-positive breast cancer, ribosomal function, innate immunity, cytoplasmic activity 
SLC9A3R1	gene symbol: SLC9A3R1. Functionality: encodes a regulatory protein involved in ion transport and cellular signaling. Phenotype: associated with cell proliferation and survival in her2-positive breast cancer. 
FN1	gene symbol: FN1. Functionality: integrin binding, extracellular matrix constituent, protease and receptor binding, angiogenesis, cell adhesion, phosphorylation regulation, signaling, wound healing, fibroblast proliferation. Phenotype: increased cell proliferation, migration, adhesion, heart and nervous system development, negative regulation of tgf-beta production, monocyte activation. 
COL1A1	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth regulation, signaling pathways. Phenotype: breast cancer, aggressive tumor growth, poor prognosis. 
EEF2	gene symbol: EEF2. Functionality: translation elongation, gtpase activity, rna binding, ribosome binding, protein binding, kinase binding, gtp binding, cadherin binding. Phenotype: her2-positive breast cancer, affects translational elongation, regulation of translation, hematopoietic progenitor cell differentiation. 
IGHG4	gene symbol: IGHG4. Functionality: adaptive immune response, b cell receptor signaling, antigen binding, complement activation, classical pathway. Phenotype: associated with immune response regulation, potential impact on her2-positive breast cancer treatment outcomes 
CALML5	gene symbol: CALML5. Functionality: protein binding, signal transduction, epidermis development, microtubule organization, enzyme regulation, calcium ion binding. Phenotype: affects epidermis, signal pathways, cytoskeleton stability 
CD74	gene symbol: CD74. Functionality: cytokine receptor activity, mhc class ii binding, antigen processing, immune response regulation, protein binding, protein stabilization, macrophage migration inhibitory factor signaling, cell surface activity, chaperone activity, positive regulation of gene expression and kinase activity. Phenotype: her2-positive breast cancer, immune response modulation, t cell selection, b cell proliferation, cytokine production, regulation of apoptosis, fibroblast proliferation, negative regulation of viral entry, dna damage response regulation. 
B2M	gene symbol: HER2. Functionality: protein binding, mhc class i antigen presentation, t cell activation, immune response regulation, iron ion transport, neuron development regulation. Phenotype: her2-positive breast cancer, increased epithelial cell proliferation, altered immune response 
FASN	gene symbol: FASN. Functionality: fatty acid synthase activity, acyl-carrier-protein transferase activity, protein binding, fatty acid metabolic process, biosynthetic process involvement, phosphopantetheine binding, cadherin binding, interleukin-4 response, modulation of viral process. Phenotype: osteoblast differentiation, glandular epithelial and mammary gland development, neutrophil and monocyte differentiation, endothelial barrier establishment, inflammation, her2-positive breast cancer association. 
S100A9	gene symbol: S100A9. Functionality: calcium ion binding, protein binding, microtubule binding, zinc ion binding, antioxidant activity, toll-like receptor-4 binding, arachidonate binding, rage receptor binding. Phenotype: involved in inflammatory response, autophagy, apoptosis, cell signaling, neuron projection development, cell growth, immune response, cytoskeleton organization, respiratory burst regulation, oxidant detoxification, apoptosis regulation. 
MGP	gene symbol: HER2. Functionality: oncogene, receptor tyrosine kinase, cell signaling, proliferation, survival. Phenotype: breast cancer, aggressive tumors, poor prognosis, increased growth, her2-positive 
CFL1	gene symbol: CFL1. Functionality: actin filament binding, cytoskeleton organization, rho protein signal transduction, viral response, cell morphogenesis regulation, embryonic development regulation, apoptotic process regulation. Phenotype: her2-positive breast cancer: altered cell structure, growth, and survival, cytoskeletal reorganization, enhanced viral processes 
PSMD3	gene symbol: PSMD3. Functionality: protein binding, enzyme regulator activity, regulation of protein catabolic process, proteasome-mediated ubiquitin-dependent protein catabolic process. Phenotype: her2-positive breast cancer, cellular protein degradation, gene expression regulation 
IGHG1	gene symbol: IGHG1. Functionality: antigen binding, fc-gamma receptor binding, adaptive immune response, b cell signaling, complement-dependent cytotoxicity. Phenotype: her2-positive breast cancer, adaptive immune response, antibody-dependent cytotoxicity, complement activation 
HLA-A	gene symbol: HLA-A. Functionality: antigen presentation, t cell activation, cytokine production regulation, immune response mediation, peptide binding, signaling receptor binding. Phenotype: involvement in her2-positive breast cancer, t cell mediated cytotoxicity, immune response to bacteria, interferon production, cd8+ t cell proliferation. 
S100A6	gene symbol: S100A6. Functionality: calcium ion binding, protein binding, signal transduction, axonogenesis, transmembrane transport, fibroblast proliferation. Phenotype: her2-positive breast cancer progression, cell proliferation, metastasis. 
MYL6	gene symbol: MYL6. Functionality: microfilament motor activity, cytoskeletal motor activity, calcium ion binding, protein binding, structural constituent of muscle, involved in muscle contraction, skeletal muscle tissue development, muscle filament sliding, located in cytosol, brush border, membrane, vesicle, extracellular exosome, part of myosin complex, unconventional myosin complex, myosin ii complex. Phenotype: contributes to muscle contractility and structure, impacts skeletal muscle development, influences cell motility and signaling, involvement in her2-positive breast cancer progression 
COL1A2	gene symbol: HER2. Functionality: oncogene, receptor tyrosine kinase, promotes cell proliferation, inhibits apoptosis. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis. 
PHB	gene symbol: PHB. Functionality: regulates mitochondrial function, cell proliferation, and apoptosis. Phenotype: associated with cell growth and survival in her2-positive breast cancer. 
TAGLN2	gene symbol: TAGLN2. Functionality: protein binding, cadherin binding, actin filament binding, actin filament organization, epithelial cell differentiation. Phenotype: her2-positive breast cancer association, impacts cell differentiation and cytoskeleton arrangement 
HLA-E	gene symbol: HLA-E. Functionality: immune signaling, antigen presentation, natural killer cell regulation, t cell activation, cytokine production. Phenotype: immune response modulation, nk cell tolerance, cytotoxicity regulation, cd8 t cell proliferation 
HLA-C	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth, differentiation. Phenotype: overexpression in breast cancer, tumor progression, poor prognosis. 
KRT7	gene symbol: KRT7. Functionality: protein binding, structural component of skin epidermis, involved in intermediate filament organization and keratinization. Phenotype: associated with cellular structural integrity, impacting skin and potentially influencing her2-positive breast cancer progression. 
CD63	gene symbol: CD63. Functionality: regulates potassium ion transport, protein binding, receptor internalization, cell-matrix adhesion, protein transport, cell migration, endosome to melanosome transport, vegf signaling, integrin-mediated signaling. Phenotype: involved in her2-positive breast cancer progression via cell migration and signaling pathways; influences pigment granule maturation, vascular growth, and adhesion. 
SYNGR2	gene symbol: SYNGR2. Functionality: protein binding, regulated exocytosis, synaptic vesicle membrane organization. Phenotype: impacts synaptic vesicle membrane function, localized in lipid droplets, membranes, extracellular exosomes, synaptic vesicle membrane, active in neuromuscular junction 
STARD3	gene symbol: STARD3. Functionality: cholesterol binding, cholesterol transfer, protein binding, protein homodimerization, lipid metabolic process, mitochondrial transport, steroid metabolic process, vesicle tethering. Phenotype: her2-positive breast cancer linked, altered cholesterol metabolism, disrupted cellular transport and signaling 
PABPC1	gene symbol: PABPC1. Functionality: mrna binding, translation activation, mrna stabilization, rna splicing, gene silencing, viral replication regulation. Phenotype: her2-positive breast cancer association, mrna decay modulation, poly(a) tail shortening regulation 
GPX4	gene symbol: GPX4. Functionality: glutathione peroxidase activity, protein binding, selenium binding, phospholipid metabolic process, apoptotic process, oxidative stress response, spermatogenesis, dendrite development, arachidonate metabolism, cellular oxidant detoxification, negative regulation of ferroptosis. Phenotype: her2-positive breast cancer association, chromatin organization, cerebellum development, multicellular organism growth, estradiol response, lipopolysaccharide response, long-chain fatty acid biosynthesis, protein polymerization. 
GRB7	gene symbol: GRB7. Functionality: enables rna binding, protein binding, protein kinase binding, phosphatidylinositol binding, identical protein binding; involved in egf receptor signaling, regulates cell migration, stress granule assembly. Phenotype: associated with her2-positive breast cancer; influences cell proliferation, migration, and stress response mechanisms. 
SLC25A6	gene symbol: SLC25A6. Functionality: atp:adp antiporter activity, protein binding, apoptotic process, mitochondrial adp/atp transport, tim23 complex involvement. Phenotype: her2-positive breast cancer association, altered mitochondrial function, apoptosis modulation 
AEBP1	gene symbol: AEBP1. Functionality: regulates transcription, ecm organization, collagen binding, calmodulin binding, zinc ion binding. Phenotype: involved in extracellular matrix structure, transcription regulation, possibly impacts tumor progression. 
GNAS	gene symbol: ERBB2. Functionality: signal transduction, cell growth, differentiation, protein binding, gtpase activity, adenylate cyclase activation. Phenotype: her2-positive breast cancer, affects cell proliferation, survival, and metastasis. 
NDUFB9	gene symbol: NDUFB9. Functionality: protein binding, nadh dehydrogenase activity, mitochondrial electron transport, proton transmembrane transport. Phenotype: her2-positive breast cancer, mitochondrial dysfunction 
EDF1	gene symbol: ERBB2 (HER2). Functionality: receptor tyrosine kinase activity, signal transduction, cell growth regulation. Phenotype: overexpression leads to her2-positive breast cancer, aggressive tumor growth. 
CRIP2	gene symbol: CRIP2. Functionality: protein binding, zinc ion binding, regulation of cell proliferation, involvement in hemopoiesis. Phenotype: her2-positive breast cancer progression, altered cell proliferation, hemopoietic changes 
DDX5	gene symbol: DDX5. Functionality: rna helicase activity, atp binding, rna binding, chromatin remodeling, mrna splicing, transcription regulation, mirna processing, histone chaperone activity, protein binding. Phenotype: her2-positive breast cancer, epithelial to mesenchymal transition, dna damage response regulation, myoblast differentiation regulation, androgen receptor signaling pathway involvement 
OAZ1	gene symbol: HER2. Functionality: protein binding, ornithine decarboxylase inhibition, polyamine biosynthesis, protein catabolism regulation, intracellular protein transport regulation, viral translational frameshifting. Phenotype: her2-positive breast cancer, increased cell proliferation, tumor progression 
EIF4G1	gene symbol: EIF4G1. Functionality: rna binding, mrna binding, translation initiation, protein binding, atp binding, eukaryotic initiation factor 4e binding, molecular adaptor activity. Phenotype: behavioral fear response, neuron differentiation, lung development, cellular response to nutrients, response to ethanol, energy homeostasis, regulation of cell growth, stress response, presynapse assembly. 
LMNA	gene symbol: HER2. Functionality: receptor tyrosine kinase activity, cell growth, proliferation regulation, protein binding, dimerization. Phenotype: overexpression leads to breast cancer progression, cell proliferation, tumor aggressiveness, poor prognosis. 
GNB2	gene symbol: GNB2. Functionality: enables gtpase activity, protein binding, signaling receptor complex adaptor activity; involved in gpcr signaling, regulation of potassium ion transport; part of heterotrimeric g-protein complex. Phenotype: associated with her2-positive breast cancer, impacts cellular signaling, influences cancer progression and response to treatment. 
CST3	gene symbol: CST3. Functionality: amyloid-beta binding, protease binding, endopeptidase inhibitor, cysteine-type endopeptidase inhibitor, protein binding, peptidase inhibitor, identical protein binding, defense response, regulation of peptidase activity, regulation of collagen catabolic process, extracellular matrix disassembly, tissue remodeling, proteolysis, elastin catabolic process, blood vessel remodeling, fiber organization. Phenotype: her2-positive breast cancer, extracellular region presence, endoplasmic reticulum activity, golgi apparatus, plasma membrane, extracellular exosome, granule lumen activity, cytoplasm, vesicle activity. 
PCGF2	gene symbol: PCGF2. Functionality: dna binding, protein binding, metal ion binding, negative regulation of transcription by rna polymerase ii, chromatin remodeling, part of pcg protein complex, prc1 complex. Phenotype: her2-positive breast cancer, affects embryonic development, anterior/posterior pattern specification, embryonic skeletal morphogenesis, apoptosis regulation, cellular response to hydrogen peroxide 
SDC1	gene symbol: SDC1. Functionality: protein binding, cargo receptor activity, identical protein binding, receptor-mediated endocytosis, cell migration. Phenotype: her2-positive breast cancer, ureteric bud development, myoblast development, striated muscle cell development, sertoli cell development, exosomal secretion. 
S100A11	gene symbol: S100A11. Functionality: protein binding, homodimerization, calcium-dependent binding, cadherin binding, signal transduction, negative regulation of dna replication and cell proliferation, positive regulation of smooth muscle migration, cell adhesion. Phenotype: her2-positive breast cancer involves altered cell adhesion and migration, abnormal signal transduction, disrupted cell cycle regulation, and changes in proliferation. 
PRDX1	gene symbol: PRDX1. Functionality: peroxidase activity, rna binding, protein binding, cadherin binding, thioredoxin peroxidase activity, hydrogen peroxide catabolism, nf-kappab signal transduction, mapk cascade regulation, redox homeostasis, oxidative stress response. Phenotype: cell proliferation, nk cell activation, erythrocyte homeostasis, fibroblast proliferation, leukocyte activation, skeletal development, superoxide radical removal. 
GRINA	gene symbol: GRINA. Functionality: protein binding, transmembrane transporter binding, calcium channel activity, regulates calcium ion homeostasis, apoptotic signaling. Phenotype: regulates apoptosis, impacts endoplasmic reticulum stress response, involved in cell survival, implicated in her2-positive breast cancer. 
ATP6V0B	gene symbol: ATP6V0B. Functionality: protein binding, proton-transporting atpase activity, rotational mechanism, vacuolar acidification, lysosomal lumen acidification, macroautophagy regulation, endosomal lumen acidification, intracellular ph reduction, golgi lumen acidification, proton transmembrane transport. Phenotype: involved in her2-positive breast cancer through membrane acidification processes, potential impact on cellular environment affecting cancer cell proliferation. 
TFF3	gene symbol: TFF3. Functionality: protein binding, identical protein binding, regulation of glucose metabolism, maintenance of gastrointestinal epithelium. Phenotype: her2-positive breast cancer, gastrointestinal epithelial integrity 
HLA-DRA	gene symbol: HER2. Functionality: her2 is a member of the human epidermal growth factor receptor (egfr) family involved in cell growth and differentiation. it is overexpressed in some breast cancers, promoting cell proliferation and survival. Phenotype: her2-positive breast cancer is characterized by aggressive tumor growth and poor prognosis. it is associated with increased tumor size, higher grade, and potential resistance to hormone therapy. 
EEF1D	gene symbol: EEF1D. Functionality: translation elongation, rna binding, transcription regulation, heat shock binding, guanyl-nucleotide exchange. Phenotype: her2-positive breast cancer progression, transcriptional regulation, stress response 
AZGP1	gene symbol: AZGP1. Functionality: rna nuclease activity, protein binding, transmembrane transport, immune response, cell adhesion, antigen processing. Phenotype: her2-positive breast cancer, impacts cell proliferation, influences immune response, affects sensory perception, associated with extracellular and nuclear locations 
PPP1CA	gene symbol: PPP1CA. Functionality: protein dephosphorylation, phosphatase activity, rna polymerase ii regulation, glycogen metabolism, chromatin remodeling, cell division, wnt signaling regulation, circadian rhythm, cell-cell adhesion. Phenotype: her2-positive breast cancer, cell proliferation, apoptosis regulation, stress response, telomere maintenance, lung development, circadian clock regulation. 
FLNA	gene symbol: FLNA. Functionality: actin binding, kinase binding, receptor binding, cytoskeleton organization, protein stabilization, cell migration regulation, transcription regulation. Phenotype: her2-positive breast cancer, neural development, cardiac morphogenesis, blood coagulation, platelet activation, cell adhesion, angiogenesis 
COL3A1	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth and differentiation, signal transduction. Phenotype: breast cancer, oncogenic transformation, tumor progression, resistance to therapy. 
ATP5E	gene symbol: ATP5E. Functionality: encodes subunit of atp synthase involved in atp production during oxidative phosphorylation. Phenotype: altered expression linked to cancer cell proliferation and survival. 
SPDEF	gene symbol: SPDEF. Functionality: dna-binding transcription factor, rna polymerase ii-specific, regulates transcription, protein binding, sequence-specific dna binding, cell differentiation. Phenotype: involved in epithelial cell development, glandular epithelial cell development, lung goblet cell differentiation, intestinal epithelial cell development, influences cell fate commitment, and apoptotic processes. 
AP000769.1	gene symbol: ERBB2. Functionality: encodes receptor tyrosine kinase, involved in cell growth and differentiation. Phenotype: associated with her2-positive breast cancer, leading to aggressive tumor growth. 
ALDOA	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth and differentiation, signal transduction. Phenotype: breast cancer, increased tumor growth, metastasis, poor prognosis. 
PLXNB2	gene symbol: PLXNB2. Functionality: transmembrane signaling receptor activity, protein binding, semaphorin receptor activity, regulation of protein phosphorylation, receptor-mediated endocytosis, cell adhesion, neuroblast proliferation, brain development, gtpase activity regulation, translation regulation, semaphorin-plexin signaling. Phenotype: neural tube closure, brain development, neuron projection development, neuron migration, axonogenesis, excitatory synapse assembly, synapse assembly, cell shape regulation, cell migration regulation. 
TAGLN	gene symbol: TAGLN. Functionality: actin binding, protein binding, involved in muscle development and epithelial cell differentiation. Phenotype: linked to her2-positive breast cancer, affects cytoplasmic function and cell differentiation. 
TUBA1B	gene symbol: TUBA1B. Functionality: enables rna binding, gtpase activity, structural molecule activity, cytoskeleton structuring, protein binding, gtp binding, ubiquitin ligase binding. involved in microtubule organization, intracellular transport, cell division, interleukin-4 response. Phenotype: affects cytoskeleton integrity, influences cell cycle, contributes to intracellular transport, impacts cell division processes. 
APOC1	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth, differentiation, survival. Phenotype: breast cancer, overexpression, aggressive tumor growth. 
PRRC2A	gene symbol: PRRC2A. Functionality: rna binding, protein binding, cell differentiation. Phenotype: her2-positive breast cancer 
LAPTM5	gene symbol: LAPTM5. Functionality: protein binding, ubiquitin ligase binding, sequestering, involved in tumor defense, cytokine regulation, protein targeting to lysosome, intracellular transport, apoptosis, ubiquitination, signaling regulation, lysosomal permeability. Phenotype: her2-positive breast cancer; immune modulation, cytokine production, apoptotic signaling, lysosome transport, receptor and protein catabolism, nf-kappab signaling, tumor necrosis factor pathway, autophagic cell death regulation. 
PTMS	gene symbol: PTMS. Functionality: involved in immune system, dna replication, transcription regulation by rna polymerase ii, apoptotic process regulation, histone binding. Phenotype: her2-positive breast cancer, affects cell proliferation and survival. 
KRT18	gene symbol: KRT18. Functionality: rna binding, structural molecule activity, protein binding, scaffold protein binding, cadherin binding, cell-cell adhesion, involved in morphogenesis, tnf-mediated signaling, golgi to plasma membrane transport, negative regulation of apoptosis, cytoskeleton organization, extrinsic apoptotic signaling, hepatocyte apoptosis. Phenotype: her2-positive breast cancer, affects intermediate filament cytoskeleton, impacts cell adhesion and apoptosis, influences morphogenesis and signaling pathways 
IFI27	gene symbol: HER2. Functionality: protein binding, lamin binding, molecular adaptor activity, transcription regulation, protein export regulation, apoptotic process, immune response, viral defense, proteasome-mediated degradation. Phenotype: her2-positive breast cancer, increased cell proliferation, enhanced survival, resistance to apoptosis, potential target for therapy. 
PLD3	gene symbol: PLD3. Functionality: enables phospholipase d activity, protein binding, single-stranded dna 5'-3' exonuclease activity; involved in immune system, dna metabolism, inflammatory response, myotube differentiation, cytokine regulation. Phenotype: associated with her2-positive breast cancer, influences cancer cell proliferation, tumor growth, and therapeutic response. 
ADAM15	gene symbol: ADAM15. Functionality: metalloendopeptidase activity, integrin binding, protein binding, metallopeptidase activity, sh3 domain binding, immunoglobulin receptor binding, metal ion binding, proteolysis. Phenotype: angiogenesis, negative regulation of cell-matrix adhesion, immune response to tumor cell, cell-matrix adhesion, integrin-mediated signaling, male gonad development, extracellular matrix disassembly, negative regulation of cell growth and migration, collagen catabolic process, tissue regeneration, innate immune response, cardiac epithelial to mesenchymal transition. 
C1QA	gene symbol: C1QA. Functionality: amyloid-beta binding, protein binding, microglial cell activation, complement activation, classical pathway, cell-cell signaling, neuron remodeling, innate immune response, astrocyte activation, synapse organization, synapse pruning, complement-mediated synapse pruning, vertebrate eye-specific patterning. Phenotype: her2-positive breast cancer: increased proliferation, invasiveness, poor prognosis. 
AES	gene symbol: AES. Functionality: inhibits transcriptional activation by tcf/lef, interacts with other transcriptional regulators. Phenotype: altered cell growth and differentiation, potential tumor suppressor role in her2-positive breast cancer. 
TSPO	gene symbol: TSPO. Functionality: androgen binding, protein binding, benzodiazepine receptor activity, cholesterol binding, cholesterol transfer, transmembrane transporter binding. Phenotype: mitochondrial targeting, steroid hormone biosynthesis, heme biosynthesis, anion transport, chloride transport, steroid metabolism, glial cell migration, xenobiotic response, axon regeneration, sterol transport, adrenal gland development, tumor necrosis factor regulation, cell proliferation, cholesterol homeostasis, apoptosis regulation, mitochondrial depolarization, calcium ion transport, cell necrosis. 
MLLT6	gene symbol: MLLT6. Functionality: protein binding, nucleosome binding, histone binding, metal ion binding, chromatin organization, transcription regulation, sodium ion transport, urine volume regulation, renal sodium and potassium excretion, renal water absorption, active in nucleus. Phenotype: her2-positive breast cancer association, affects transcription regulation, impacts renal functions including sodium and potassium excretion, may influence breast cancer progression 
TAPBP	gene symbol: TAPBP. Functionality: protein binding, mhc class i binding, peptide antigen binding, protein folding chaperone, tap1/tap2 binding, molecular adaptor activity, tap complex binding. Phenotype: mhc class i peptide loading, antigen processing, protein complex assembly, gene expression regulation, endoplasmic reticulum activity, golgi to er transport, protein stability. 
SCAND1	gene symbol: ERBB2. Functionality: protein tyrosine kinase receptor in cell growth signaling pathways. Phenotype: overexpression leads to her2-positive breast cancer with increased cell proliferation. 
ATP1A1	gene symbol: ATP1A1. Functionality: sodium-potassium pump, atp hydrolysis, ion transport, transmembrane gradient, phosphatase activity, protein binding. Phenotype: cardiac muscle contraction regulation, blood pressure regulation, ion homeostasis, cardiac conduction, osmosensory signaling, response to xenobiotic. 
CD81	gene symbol: HER2. Functionality: receptor tyrosine kinase, cell growth, differentiation, survival, mapk, pi3k/akt pathways. Phenotype: breast cancer, aggressive tumor growth, metastasis, poor prognosis 
SEC61A1	gene symbol: SEC61A1. Functionality: transmembrane protein translocation, calcium channel activity, ribosome binding, er organization. Phenotype: associated with her2-positive breast cancer, affects protein targeting and calcium transport. 
CLDN3	gene symbol: CLDN3. Functionality: enables transmembrane signaling, protein binding, cell adhesion, structural activity, regulates gene expression, acts in cell junctions, tight junctions, plasma membrane. Phenotype: involved in epithelial morphogenesis, hypoxia response, regulates cell migration, proliferation, wound healing, blood-brain barrier maintenance, affects membrane permeability, tight junction assembly. 
PPDPF	gene symbol: PPDPF. Functionality: involved in liver development, cell differentiation, torc1 signaling, mitochondrial localization. Phenotype: associated with her2-positive breast cancer progression 
S100A14	gene symbol: S100A14. Functionality: calcium ion binding, protein binding, chemokine receptor binding, involved in apoptotic process, response to lipopolysaccharide, tlr4 signaling, bacterial defense, calcium homeostasis, granulocyte chemotaxis, monocyte chemotaxis. Phenotype: her2-positive breast cancer association, impacts immune response, affects cell signaling, influences apoptosis. 
BGN	gene symbol: BGN. Functionality: extracellular matrix structural constituent, protein binding, glycosaminoglycan binding, cytokine binding, compression resistance. Phenotype: involved in bone development, articular cartilage development, her2-positive breast cancer progression. 
C3	gene symbol: ERBB2. Functionality: protein tyrosine kinase activity, cell growth, differentiation; involved in signal transduction, immune response, receptor-mediated endocytosis, angiogenesis. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis, high recurrence rate. 
MZT2B	gene symbol: MZT2B. Functionality: protein binding, part of gamma-tubulin ring complex, active in centrosome and spindle. Phenotype: her2-positive breast cancer progression, mitotic spindle assembly 
S100A8	gene symbol: S100A8. Functionality: calcium, zinc, and arachidonate binding; microtubule and protein binding; toll-like receptor 4 and rage receptor interaction; regulates inflammatory response, leukocyte migration, autophagy, apoptosis, and nf-kappab activity. Phenotype: involves inflammatory response, immune defense, cell growth regulation, neutrophil chemotaxis and aggregation, cytoskeleton organization, and response to pathogens; located in extracellular regions, nucleus, cytosol, and plasma membrane. 
MDK	gene symbol: MDK. Functionality: protein binding, growth factor activity, heparin binding, chondroitin sulfate binding, heparan sulfate binding, signal transduction, cell differentiation, cell migration, proliferation, tissue regeneration. Phenotype: regulation of immune response, nervous system development, inflammatory response, cell adhesion, vascular development, neuronal processes, epithelial-mesenchymal transition, cartilage development, apoptosis regulation. 
PFDN5	gene symbol: ERBB2. Functionality: receptor tyrosine kinase activity, signal transduction, cell growth, differentiation. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis 
H2AFJ	gene symbol: H2AFJ. Functionality: histone h2a family member involved in chromatin structure modulation and gene regulation. Phenotype: alterations associated with her2-positive breast cancer progression. 
SH3BGRL3	gene symbol: SH3BGRL3. Functionality: protein binding, cytoskeleton organization, located in cytosol, nuclear body, ruffle membrane, extracellular exosome, active in cytoplasm. Phenotype: involved in her2-positive breast cancer, affects cellular structure and signaling 
ENO1	gene symbol: ENO1. Functionality: magnesium ion binding, dna binding, transcription repressor, rna binding, phosphopyruvate hydratase activity, protein binding, rna polymerase ii regulation, gluconeogenesis, glycolysis, plasminogen activation regulation, atp biosynthesis regulation. Phenotype: her2-positive breast cancer, altered transcription, cell growth regulation, virus response, muscle contraction regulation, apoptosis regulation, metabolic processes. 
XBP1	gene symbol: XBP1. Functionality: transcription factor, regulates rna polymerase ii, involved in er stress response, protein phosphorylation, cell proliferation, immune response, and lipid biosynthesis. Phenotype: influences her2-positive breast cancer progression, impacts cell growth, apoptosis, angiogenesis, and differentiation of b, t, and fat cells. 
CYBA	gene symbol: CYBA. Functionality: nadph oxidase component, superoxide generation, electron transfer, protein binding, sh3 domain binding, heme binding, metal ion binding, heterodimerization, inflammatory response, interleukin-6 regulation, tnf regulation, toll-like receptor signaling, immune response, respiratory burst. Phenotype: her2-positive breast cancer, inflammatory processes, smooth muscle hypertrophy, cytochrome assembly, superoxide metabolism, enhanced phagocytosis, calcium ion regulation, mucus secretion, defense response to bacteria, ros biosynthesis 
COX6B1	gene symbol: ERBB2. Functionality: encodes a receptor tyrosine kinase involved in signal transduction pathways, promoting cell growth and differentiation. Phenotype: overexpression associated with aggressive her2-positive breast cancer, leading to increased cell proliferation and poor prognosis. 
TRAF4	gene symbol: TRAF4. Functionality: tumor necrosis factor receptor binding, protein binding, zinc ion binding, transferase activity, protein kinase binding, ubiquitin protein ligase binding, thioesterase binding, identical protein binding, ww domain binding, signaling adaptor activity. Phenotype: apoptotic process regulation, respiratory gaseous exchange, respiratory tube development, innate immune response, positive regulation of protein kinase activity, positive regulation of jnk cascade, proteasome-mediated protein catabolism, cell surface receptor signaling, nf-kappab signal transduction 
CD24	gene symbol: CD24. Functionality: protein binding, kinase binding, tyrosine kinase activator, cell activation, cytokine signaling, immune response, calcium regulation, wnt signaling, cell migration, epithelial differentiation, t cell costimulation, b cell transport, map kinase regulation, cholesterol homeostasis, estrogen response. Phenotype: her2-positive breast cancer, cell proliferation, migration, immune modulation, apoptosis, differentiation, adhesion, hypoxia response, bacterial response. 
PRSS8	gene symbol: PRSS8. Functionality: serine-type endopeptidase activity, protein binding, proteolysis, regulation of sodium ion transport. Phenotype: linked to her2-positive breast cancer, affects sodium ion regulation and cellular proteolysis. 
MMP14	gene symbol: MMP14. Functionality: endopeptidase activity, integrin binding, zinc ion binding, extracellular matrix organization, angiogenesis, proteolysis, protein processing, cell migration, tissue remodeling, focal adhesion regulation. Phenotype: her2-positive breast cancer, increased cell motility, enhanced tissue remodeling, altered angiogenesis, modified extracellular matrix, impact on cancer progression. 
MUC1	gene symbol: MUC1. Functionality: rna polymerase ii binding, p53 binding, transcription coregulation, protein binding, dna damage response, signal transduction, transcription regulation, cell adhesion regulation, apoptosis regulation. Phenotype: her2-positive breast cancer, cell cycle arrest, transcription alteration, impaired cell adhesion, apoptosis inhibition 
VIM	gene symbol: VIM. Functionality: structural support, rna binding, protein binding, mrna stabilization, gene expression regulation, collagen biosynthesis regulation. Phenotype: associated with cellular structure integrity, neuron development, astrocyte development, immune response, cancer metastasis potential. 
MIDN	gene symbol: MIDN. Functionality: protein binding, kinase binding, molecular adaptor activity, protein catabolism, regulation of glucokinase, insulin secretion. Phenotype: her2-positive breast cancer, protein regulation, cytoplasmic and nuclear activity 
SPINT2	gene symbol: SPINT2. Functionality: negative regulation of cell adhesion and motility, endopeptidase inhibitor activity, cell polarity maintenance, epithelial morphogenesis, basement membrane organization, response to bmp stimulus. Phenotype: involved in neural tube closure, placental branching, negative regulation of neural precursor cell proliferation; associated with her2-positive breast cancer. 
BST2	gene symbol: BST2. Functionality: regulates leukocyte proliferation, rna binding, protein binding, metalloendopeptidase inhibition, homodimerization, nf-kappab signaling, cytokine production, viral defense, actin cytoskeleton, cell growth, migration. Phenotype: involvement in immune response, viral replication inhibition, b cell activation, interferon response, intracellular viral transport regulation, cell surface expression. 
TIMP1	gene symbol: TIMP1. Functionality: protease binding, cytokine activity, protein binding, growth factor activity, metalloendopeptidase inhibitor, zinc ion binding, peptidase inhibitor, regulation of cell proliferation, regulation of apoptosis, regulation of catalytic activity, regulation of metallopeptidase activity, integrin-mediated signaling. Phenotype: connective tissue replacement, wound healing, cartilage development, response to uv-a, response to cytokine, response to peptide hormone, regulation of trophoblast cell migration, active in extracellular matrix and space. 
GUK1	gene symbol: GUK1. Functionality: guanylate kinase activity, protein binding, atp binding, purine nucleotide metabolism, dgdp biosynthesis, xenobiotic metabolism, nucleobase interconversion, gmp and dgmp metabolism. Phenotype: involved in her2-positive breast cancer, affecting cellular processes in mitochondria and cytosol. 
ACTN4	gene symbol: ACTN4. Functionality: actin cytoskeleton colocalization, rna polymerase ii transcription regulation, nucleoside and rna binding, transcription coactivator, integrin and calcium ion binding, chromatin dna and transmembrane transporter binding. Phenotype: involved in cell migration, tumor necrosis factor signaling, apoptotic process regulation, sodium:proton antiporter activity, non-canonical nf-kappab signal transduction, actin cytoskeleton organization, muscle cell development. 
CTSB	gene symbol: CTSB. Functionality: enables cysteine-type endopeptidase activity, protein binding, collagen binding, proteolysis, thyroid hormone generation, apoptosis regulation, decidualization, symbiont entry facilitation. Phenotype: involved in her2-positive breast cancer progression, extracellular matrix remodeling, epithelial cell differentiation, collagen catabolism, cellular response to thyroid hormones. 
COX4I1	gene symbol: ERBB2. Functionality: encodes receptor tyrosine kinase, promotes cell proliferation, differentiation, survival. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis, targeted therapy candidate. 
CCT3	gene symbol: CCT3. Functionality: telomere maintenance, rna binding, protein binding, atp binding, atp hydrolysis, protein folding, sperm-zona pellucida binding, protein stabilization, localization to telomere and cajal body. Phenotype: her2-positive breast cancer association, cellular protein folding, telomere regulation, sperm-egg interaction. 
HNRNPA2B1	gene symbol: HNRNPA2B1. Functionality: rna binding, mrna processing, mirna binding, telomere maintenance, spliceosomal activity, rna transport. Phenotype: her2-positive breast cancer association, mrna splicing regulation, mirna processing impact, telomere length alteration. 
SEPW1	gene symbol: SEPW1. Functionality: encodes selenoprotein w; involved in redox homeostasis and antioxidant defense. Phenotype: altered expression linked to tumor progression; potential role in her2-positive breast cancer. 
LY6E	gene symbol: LY6E. Functionality: protein binding; cell surface receptor signaling; negative regulation of viral entry; acetylcholine receptor binding and inhibition. Phenotype: her2-positive breast cancer modulation; altered receptor signaling; potential impact on viral infections. 
SCD	gene symbol: SCD. Functionality: stearoyl-coa desaturase activity, iron ion binding, protein binding, oxidoreductase activity, palmitoyl-coa desaturase activity. Phenotype: involvement in unsaturated fatty acid biosynthesis, regulation of thermogenesis, response to fatty acids, location in nucleolus and endoplasmic reticulum membrane 
HSPB1	gene symbol: HSPB1. Functionality: rna binding, protein kinase c binding, protein binding, kinase inhibitor activity, protein homodimerization, ubiquitin binding, chaperone activity, transcription factor binding, regulation of phosphorylation, translation initiation, response to stress, signal transduction, angiogenesis. Phenotype: her2-positive breast cancer, regulation of apoptosis, inflammation, autophagy, protein transport, oxidative stress response, endothelial cell migration 
EIF4G2	gene symbol: EIF4G2. Functionality: rna binding, translation initiation factor activity, protein binding, cadherin binding, regulation of translational initiation, regulation of cell cycle, mrna binding. Phenotype: involved in heart development, cell death, macromolecule biosynthesis, autophagy regulation, cell growth, translation, axon extension, dendritic spine development; located in cytosol, adherens junction, membrane, axon 
BSG	gene symbol: BSG. Functionality: protein localization, virus receptor activity, protein binding, signaling receptor, cadherin binding, angiogenesis, embryo implantation, vegf regulation, endothelial migration, interleukin-6 regulation, viral entry, symbiont entry, homophilic cell adhesion, axon guidance. Phenotype: her2-positive breast cancer, neural retina development, photoreceptor maintenance, odontogenesis, endothelial tube morphogenesis, chemotaxis, decidualization, response to hormones, plasma membrane activity. 
ZYX	gene symbol: ZYX. Functionality: rna binding, protein binding, metal ion binding, cell-matrix adhesion, tgf-beta receptor signaling, integrin signaling, cell-cell signaling, stress fiber assembly, type ii interferon response. Phenotype: her2-positive breast cancer, cell adhesion, cytoskeletal organization, signal transduction, cellular stress response 
TUBB	gene symbol: ERBB2. Functionality: receptor tyrosine kinase activity, signal transduction, cell proliferation, differentiation, survival. Phenotype: overexpression leads to her2-positive breast cancer, aggressive tumor growth, poor prognosis. 
LASP1	gene symbol: LASP1. Functionality: protein binding, ion transmembrane transport, cadherin and metal ion binding, actin filament binding. Phenotype: her2-positive breast cancer progression, cytoplasmic localization, focal adhesion, cortical actin cytoskeleton involvement 
CD99	gene symbol: CD99. Functionality: protein binding; involved in t cell and neutrophil extravasation; homotypic cell-cell adhesion; active in cytoplasm, plasma membrane, focal adhesion. Phenotype: her2-positive breast cancer association; affects immune cell migration and adhesion. 
COL6A2	gene symbol: ERBB2. Functionality: receptor tyrosine kinase, cell growth, differentiation, signal transduction. Phenotype: breast cancer, overexpression, aggressive tumor, poor prognosis 
H1FX	gene symbol: H1FX. Functionality: involved in chromatin structure regulation and gene expression modulation. Phenotype: aberrant expression may influence tumorigenesis, associated with her2-positive breast cancer. 
RALY	gene symbol: HER2. Functionality: transcription coregulation, rna binding, protein binding, transcription regulation, mrna splicing, cholesterol homeostasis. Phenotype: her2-positive breast cancer, characterized by overexpression of her2 protein, aggressive tumor growth, potential responsiveness to targeted therapies 
UBE2M	gene symbol: UBE2M. Functionality: ubiquitin-protein transferase activity, atp binding, nedd8 transferase, protein modification, regulation of synapse assembly. Phenotype: involved in her2-positive breast cancer, affects protein neddylation, neuron apoptosis regulation, active in nucleoplasm and cytosol 
SPARC	gene symbol: SPARC. Functionality: extracellular matrix structural constituent, calcium ion binding, collagen binding, protein binding, extracellular matrix binding. Phenotype: negative regulation of endothelial cell proliferation, positive regulation of endothelial cell migration, negative regulation of angiogenesis, regulation of cell morphogenesis, semicircular canal morphogenesis, regulation of synapse organization 
ATG10	gene symbol: ATG10. Functionality: enables protein binding, atg12 transferase, atg12 conjugating enzyme activity, involved in autophagosome assembly, protein lipidation, autophagy, er overload response, protein transport, positive regulation of protein modification, protein modification by small protein conjugation. Phenotype: influences cell survival mechanisms, autophagy, and potentially impacts her2-positive breast cancer progression through modulation of autophagic pathways. 
HSP90AB1	gene symbol: HSP90AB1. Functionality: protein folding chaperone, atp binding, kinase binding, protein stabilization, rna binding, regulation of telomerase, nitric oxide biosynthesis, protein ubiquitination, apoptotic process regulation, cell cycle regulation, protein localization regulation. Phenotype: her2-positive breast cancer association, altered cell differentiation, modified apoptotic regulation, enhanced telomerase activity, potential impact on tumor progression and response to therapy. 
ORMDL3	gene symbol: ORMDL3. Functionality: regulates b cell apoptosis, autophagy, ceramide biosynthesis, protein localization to nucleus; involved in sphingolipid metabolism, smooth muscle contraction, myelination, motor behavior; protein binding; part of serine palmitoyltransferase complex. Phenotype: impacts immune response, lipid metabolism, neurological functions; associated with her2-positive breast cancer. 
LMAN2	gene symbol: LMAN2. Functionality: protein binding, d-mannose binding, carbohydrate binding, heat shock protein binding, metal ion binding, vesicle-mediated transport, protein transport, regulation of phagocytosis. Phenotype: her2-positive breast cancer involvement, golgi to er transport, extracellular space interaction, cell surface activity, exosome participation. 
CHCHD2	gene symbol: CHCHD2. Functionality: regulates mitochondrial atp synthesis, dna binding, transcription regulation, response to oxidative stress, hypoxia response. Phenotype: her2-positive breast cancer involves altered mitochondrial function, transcription regulation, stress responses. 
COX7C	gene symbol: COX7C. Functionality: mitochondrial electron transport, protein binding, energy metabolism. Phenotype: energy production alteration, potential impact on her2-positive breast cancer 
ARHGDIA	gene symbol: ARHGDIA. Functionality: gtpase activator, protein binding, regulation of rho protein signal transduction, negative regulation of apoptosis, semaphorin-plexin signaling, synaptic vesicle cycle regulation. Phenotype: her2-positive breast cancer, alterations in cell signaling pathways, potential impact on cell migration and apoptosis. 
VMP1	gene symbol: VMP1. Functionality: protein binding, phospholipid scramblase activity, autophagosome assembly, autophagy, cell junction assembly, organelle localization, atpase regulation, mitochondrion-er tethering. Phenotype: her2-positive breast cancer, embryo implantation, cell-cell adhesion, plasma membrane phospholipid scrambling, lipoprotein transport, golgi organization 
UBC	gene symbol: HER2. Functionality: protein ubiquitination, rna binding, protein binding, ubiquitin ligase binding, protein tag activity. Phenotype: her2-positive breast cancer, altered cell growth, aggressive breast cancer 
IGFBP2	gene symbol: IGFBP2. Functionality: protein binding, receptor binding, inhibitor activity, growth factor binding, signaling regulation. Phenotype: involved in cancer progression, osteoblast differentiation, nutrient response, t cell proliferation, hormone stimulus response. 
COPE	gene symbol: HER2. Functionality: protein binding, structural molecule activity, vesicle-mediated transport, protein localization, golgi and endoplasmic reticulum membrane localization, copi vesicle coat component. Phenotype: associated with her2-positive breast cancer, characterized by overexpression leading to aggressive tumor growth and poor prognosis. 
NUPR1	gene symbol: NUPR1. Functionality: dna binding, chromatin binding, transcription coactivator, protein binding, acetyltransferase activator, cell cycle regulation, autophagy regulation, apoptotic process regulation. Phenotype: negative regulation of cell cycle, response to stress, inflammation, development, apoptosis, proliferation, transcription, protein catabolism, oxidative phosphorylation, and necrotic cell death. 
PERP	gene symbol: PERP. Functionality: protein binding, tissue homeostasis, desmosome organization, notch signaling, cell-cell adhesion, regulation of proteolysis, duct morphogenesis, apoptotic signaling, neutrophil chemotaxis, amelogenesis, endopeptidase activation. Phenotype: her2-positive breast cancer, affects cell adhesion, apoptosis, tissue structure, immune response 
KRT81	gene symbol: KRT81. Functionality: protein binding, structural constituent of skin epidermis, keratinization, intermediate filament organization. Phenotype: associated with keratin filament in her2-positive breast cancer 
PPP1R1B	gene symbol: HER2. Functionality: protein kinase inhibitor, camp-dependent inhibitor, phosphatase inhibitor, protein binding, transcription, signal transduction. Phenotype: her2-positive breast cancer, tumor growth, cell proliferation, response to amphetamine, morphine, cocaine, visual learning. 
LGALS3BP	gene symbol: LGALS3BP. Functionality: scavenger receptor activity, protein binding, cellular defense response, cell adhesion, signal transduction, vesicle-mediated transport. Phenotype: her2-positive breast cancer, extracellular matrix interaction, extracellular space activity 
SSR2	gene symbol: SSR2. Functionality: protein binding, cotranslational protein targeting to membrane, located in endoplasmic reticulum and membrane. Phenotype: in her2-positive breast cancer, may influence protein processing and signaling pathways, contributing to tumor growth. 
KIAA0100	gene symbol: KIAA0100. Functionality: regulates cell growth, signal transduction. Phenotype: associated with her2-positive breast cancer progression 
MYL9	gene symbol: MYL9. Functionality: structural constituent of cytoskeleton and muscle, protein binding, myosin heavy chain binding, regulation of muscle contraction, stress fiber assembly, platelet aggregation. Phenotype: involvement in stress fiber, cytosol, cell cortex, z disc, muscle myosin complex, cytoplasm, myofibril, myofibril assembly, myosin ii complex. 
CIB1	gene symbol: CIB1. Functionality: calcium ion binding, protein binding, kinase inhibitor, gtpase binding, membrane adaptor, angiogenesis, cell proliferation regulation, apoptosis, dna repair, cell adhesion. Phenotype: involved in her2-positive breast cancer progression through cell growth, migration, adhesion, and survival modulation. 
IDH2	gene symbol: IDH2. Functionality: enables nadp+-dependent isocitrate dehydrogenase activity, involved in tca cycle, glyoxylate cycle, 2-oxoglutarate and isocitrate metabolic processes, binds magnesium ion, nad, located in mitochondrion, cytosol, peroxisome, extracellular exosome. Phenotype: altered idh2 function impacts cellular energy metabolism, potentially contributing to oncogenesis in her2-positive breast cancer 
STARD10	gene symbol: STARD10. Functionality: lipid transport, protein binding, lipid binding. Phenotype: her2-positive breast cancer progression 
LGALS1	gene symbol: LGALS1. Functionality: rna binding, protein binding, receptor ligand activity, laminin binding, lactose binding, signal transduction, cell-cell adhesion, t cell costimulation, inflammatory response regulation, nf-kappab signal transduction regulation, plasma cell differentiation, myoblast differentiation, viral entry regulation, apoptotic process regulation. Phenotype: involvement in her2-positive breast cancer, apoptotic process, negative regulation of t-helper 17 cell lineage, extracellular matrix interactions, location in cytoplasm, cytosol, endoplasmic reticulum lumen, extracellular regions, and exosomes 
COX6C	gene symbol: COX6C. Functionality: protein binding, energy generation, mitochondrial electron transport, cellular respiration. Phenotype: her2-positive breast cancer, altered energy metabolism, mitochondrial dysfunction 
GRN	gene symbol: GRN. Functionality: rna binding, cytokine activity, protein binding, growth factor activity, chaperone binding, signal transduction, regulation of immune response, lysosome organization, cell migration, apoptosis regulation, angiogenesis, axon regeneration, epithelial proliferation, protein stabilization. Phenotype: her2-positive breast cancer, immune response modulation, lysosomal function, endothelial cell migration, neuron survival, inflammatory response regulation, epithelial growth. 
MAPKAPK2	gene symbol: MAPKAPK2. Functionality: protein kinase, serine/threonine kinase, phosphoinositide-dependent kinase, dna-dependent kinase, amp-activated kinase, translation initiation, ribosomal protein s6 kinase, atp binding, histone kinase, rho-dependent kinase, chromatin remodeling, phosphorylation, inflammatory response, dna damage signaling, mrna stability, cytokine regulation. Phenotype: involvement in her2-positive breast cancer; regulation of inflammatory and immune response; affects tumor necrosis factor, interleukin-6 production; response to growth factors; intracellular signaling; cellular stress response. 
GNAI2	gene symbol: GNAI2. Functionality: gtp binding, protein binding, signal transduction, gtpase activity, receptor binding, adenylate cyclase regulation. Phenotype: cell proliferation, migration, synaptic transmission, apoptosis regulation, vascular smooth muscle and neural cell proliferation. 
KDELR1	gene symbol: KDELR1. Functionality: kdel sequence binding, protein binding, retrograde transport, golgi to er, protein transport, t cell differentiation, t cell apoptosis, er retention sequence binding. Phenotype: er and golgi membrane localization, affects vesicle-mediated transport, involved in immune cell processes. 
COL18A1	gene symbol: COL18A1. Functionality: protein binding, extracellular matrix structural constituent, metal ion binding, cell adhesion, negative regulation of cell population proliferation, response to stimuli, organ morphogenesis. Phenotype: involvement in visual perception, response to xenobiotic and hydrostatic pressure, skeletal development, extracellular matrix organization, angiogenesis, endothelial cell morphogenesis. 
UQCRQ	gene symbol: ERBB2. Functionality: encodes a receptor tyrosine kinase involved in signal transduction pathways leading to cell growth and differentiation. Phenotype: overexpression linked to her2-positive breast cancer, associated with aggressive tumor growth and poor prognosis. 
COX5B	gene symbol: ERBB2. Functionality: encodes tyrosine kinase receptor; activates signaling pathways regulating cell growth and differentiation. Phenotype: overexpression leads to her2-positive breast cancer; associated with increased tumor aggressiveness and poor prognosis. 
ELOVL1	gene symbol: ELOVL1. Functionality: fatty acid elongase, protein binding, biosynthetic processes in endoplasmic reticulum. Phenotype: her2-positive breast cancer, impacts fatty acid metabolism, skin barrier formation 
CHPF	gene symbol: CHPF. Functionality: protein binding, metal ion binding, glycosyltransferase activities, chondroitin sulfate biosynthesis. Phenotype: her2-positive breast cancer association, potential impact on cell signaling and growth 
CLDN4	gene symbol: CLDN4. Functionality: enables transmembrane signaling, structural molecule, chloride channel, protein binding, cell-cell adhesion, wound healing regulation, paracellular transport. Phenotype: involved in her2-positive breast cancer, affects cell migration, morphogenesis, skin barrier, renal absorption, progesterone response, circadian rhythm, pregnancy. 
C12orf57	gene symbol: HER2. Functionality: receptor tyrosine kinase activity, cell growth, differentiation. Phenotype: breast cancer, overexpression, aggressive tumor growth 
LGALS3	gene symbol: LGALS3. Functionality: rna binding, protein phosphatase inhibition, ige binding, carbohydrate binding, laminin binding, receptor ligand inhibition, chemoattractant activity, signaling receptor inhibition, molecular condensate scaffold activity. Phenotype: involved in immune response, monocyte and neutrophil chemotaxis, t cell regulation, epithelial differentiation, cell migration, protein localization, apoptosis regulation, extracellular matrix interaction. 
HSP90AA1	gene symbol: HSP90AA1. Functionality: telomere maintenance, utp/ctp/rna/mrna/protein/atp/gtp/datp binding, atp hydrolysis, protein folding and stabilization, chaperone-mediated activities, immune response regulation. Phenotype: her2-positive breast cancer, cellular stress response, telomerase activation, immune response enhancement, protein complex assembly, neurofibrillary tangle, cell size regulation. 
JUP	gene symbol: JUP. Functionality: transcription coactivator, structural molecule, protein binding, phosphatase binding, cell adhesion, cytoskeletal anchor, wnt signaling regulation. Phenotype: regulation of cell adhesion, migration, proliferation, skin development, heart rate; involved in desmosome assembly, angiogenesis, endothelial adhesion. 
A2M	gene symbol: HER2. Functionality: receptor tyrosine kinase, mediates cell growth and differentiation, involved in signaling pathways. Phenotype: overexpression leads to aggressive breast cancer, poor prognosis, targeted by drugs like trastuzumab. 
NDUFB7	gene symbol: ERBB2. Functionality: encodes receptor tyrosine kinase, mediates cell proliferation, survival. Phenotype: overexpression leads to her2-positive breast cancer, aggressive tumor growth. 
PGAP3	gene symbol: PGAP3. Functionality: protein binding, hydrolase activity on ester bonds, gpi anchor metabolism, gpi anchor biosynthesis. Phenotype: altered cell signaling, her2-positive breast cancer progression 
HSPA8	gene symbol: HSPA8. Functionality: protein folding, atp binding, chaperone-mediated autophagy, receptor binding, enzyme binding, rna binding, signal transduction, protein complex assembly regulation. Phenotype: cell migration regulation, transcription regulation, stress response, starvation response, cellular response to hormone, protein stability maintenance, protein targeting to lysosome. 
TCEB2	gene symbol: TCEB2. Functionality: encodes elongin b protein, regulates transcription elongation, forms complex with elongin a and c. Phenotype: involved in her2-positive breast cancer progression, influences cell proliferation and survival. 
PEBP1	gene symbol: PEBP1. Functionality: inhibits mapk cascade, binds rna, atp, proteins, kinases, enzymes, phosphatidylethanolamine, acts as serine-type endopeptidase inhibitor. Phenotype: her2-positive breast cancer, potentially alters cell signaling and proliferation. 
COPS9	gene symbol: COPS9. Functionality: protein binding, regulation of cell proliferation, response to uv, sequestering cytoplasmic protein, regulation of neddylation. Phenotype: her2-positive breast cancer association, cellular proliferation, altered protein regulation 
ATP5G2	gene symbol: ATP5G2. Functionality: encodes a subunit of mitochondrial atp synthase complex, involved in atp synthesis. Phenotype: altered expression may impact cellular energy metabolism, potentially influencing tumor growth in her2-positive breast cancer. 
ATP6AP1	gene symbol: ATP6AP1. Functionality: enables protein and small gtpase binding, transporter activator activity, atpase activator activity, involved in ph regulation, ion homeostasis, vacuolar, lysosomal, endosomal, golgi lumen acidification. Phenotype: associated with her2-positive breast cancer, affects osteoclast development, intracellular iron ion homeostasis, cellular response to oxygen levels, synaptic vesicle acidification, endosome-plasma membrane protein transport. 
MYH9	gene symbol: ERBB2. Functionality: receptor tyrosine kinase, cell growth regulation, signal transduction, dimerization, phosphorylation. Phenotype: breast cancer, aggressive tumor growth, overexpression, poor prognosis 
LSM4	gene symbol: LSM4. Functionality: rna binding, protein binding, ph domain binding, mrna splicing, mrna catabolism, snrnp assembly, p-body assembly. Phenotype: her2-positive breast cancer 
COX8A	gene symbol: COX8A. Functionality: cytochrome-c oxidase activity, protein binding, precursor metabolite generation, electron transport, cellular respiration, proton transport. Phenotype: associated with mitochondrial energy production and metabolism, potential implications in her2-positive breast cancer growth 
UQCR11	gene symbol: HER2. Functionality: encodes a receptor tyrosine kinase involved in cell growth, differentiation, and repair. Phenotype: overexpression leads to her2-positive breast cancer, characterized by aggressive tumor growth. 
ATP5B	gene symbol: ATP5B. Functionality: encodes beta subunit of atp synthase, critical for atp production in mitochondria. Phenotype: altered expression linked to cancer cell metabolism and potential resistance in her2-positive breast cancer. 
DHCR24	gene symbol: ERBB2. Functionality: encodes tyrosine kinase receptor involved in cell growth and differentiation; overexpression linked to breast cancer. Phenotype: her2-positive breast cancer characterized by rapid tumor growth, poor prognosis, and responsiveness to targeted therapies. 
PTBP1	gene symbol: PTBP1. Functionality: rna binding, protein binding, alternative mrna splicing regulation, mrna processing, rna splicing, calcineurin-nfat signaling regulation, viral translation initiation. Phenotype: her2-positive breast cancer related, affects rna splicing, cell differentiation regulation, impacts muscle cell differentiation, involved in nucleoplasm, nucleolus, membrane, extracellular exosome 
EIF3B	gene symbol: EIF3B. Functionality: translation initiation, rna binding, protein binding, molecular adaptor, cytoplasmic complex formation. Phenotype: involved in her2-positive breast cancer progression. 
NDUFA3	gene symbol: NDUFA3. Functionality: nadh dehydrogenase activity, mitochondrial electron transport, atp synthesis. Phenotype: her2-positive breast cancer progression, mitochondrial dysfunction 
FKBP2	gene symbol: FKBP2. Functionality: protein binding, fk506 binding, rna polymerase ii regulation, chaperone-mediated folding, peptidyl-prolyl cis-trans isomerase activity. Phenotype: associated with her2-positive breast cancer, involved in transcription regulation and protein folding. 
MMACHC	gene symbol: MMACHC. Functionality: protein binding, oxidoreductase activity, transferase activity, cobalamin binding, demethylase activity, cyanocobalamin reductase activity, homodimerization, glutathione binding, fad binding. Phenotype: associated with cobalamin metabolism disorders, affects methylmalonic aciduria and homocystinuria, linked to various metabolic abnormalities. 
RABAC1	gene symbol: RABAC1. Functionality: protein binding, gtpase binding, proline-rich region binding, located in plasma membrane, synaptic vesicle, golgi apparatus. Phenotype: her2-positive breast cancer association, implicated in signal transduction, cell proliferation 
ISG15	gene symbol: ISG15. Functionality: enables integrin binding, protein binding, protein tag activity, ubiquitin protein ligase binding; involved in integrin-mediated signaling, response to virus, bone mineralization, isg15-protein conjugation, interferon regulation, immune response, erythrocyte differentiation. Phenotype: alters immune response, antiviral defense, erythrocyte differentiation; affects protein localization, signaling pathways, viral replication; implicated in her2-positive breast cancer. 
PTMA	gene symbol: PTMA. Functionality: protein binding, histone binding, dna-binding transcription factor binding, dna-templated transcription, regulation of apoptosis, transcription regulation by rna polymerase ii. Phenotype: her2-positive breast cancer, transcription regulation, apoptosis modulation 
RRBP1	gene symbol: RRBP1. Functionality: rna binding, protein binding, signaling receptor activity, involved in osteoblast differentiation, translation, protein transport. Phenotype: her2-positive breast cancer involvement 
POSTN	gene symbol: POSTN. Functionality: extracellular matrix organization, cell adhesion, protein binding, heparin binding, metal ion binding, regulation of notch signaling. Phenotype: response to hypoxia, mechanical stimulus, estradiol, muscle activity, tissue development, bone regeneration, smooth muscle migration, chemokine production. 
C1QB	gene symbol: C1QB. Functionality: protein binding, complement activation, classical pathway, innate immune response, synapse pruning. Phenotype: her2-positive breast cancer progression, extracellular matrix interaction, immune modulation 
BCAP31	gene symbol: BCAP31. Functionality: protein binding, mhc class i binding, complex binding, protein targeting, intracellular transport, apoptosis, er stress response, retrograde transport regulation, erad pathway regulation, ubiquitin-dependent catabolism regulation, intrinsic apoptotic signaling regulation. Phenotype: her2-positive breast cancer, spermatogenesis, protein localization, er to golgi transport, golgi and er membrane localization, mitochondria-associated er membrane contact site. 
PSMB4	gene symbol: PSMB4. Functionality: protein binding, lipopolysaccharide binding, negative regulation of inflammatory response, proteasome-mediated protein catabolism, part of proteasome complex. Phenotype: altered inflammatory response, potential role in her2-positive breast cancer progression. 
LAPTM4A	gene symbol: LAPTM4A. Functionality: protein binding, lysosomal membrane activity, golgi apparatus localization, late endosome membrane localization. Phenotype: associated with her2-positive breast cancer progression, impacts cellular trafficking, influences drug resistance 
INTS1	gene symbol: HER2. Functionality: protein binding, rna polymerase ii regulation, snrna processing, integrator complex involvement, cell proliferation, apoptosis regulation. Phenotype: her2-positive breast cancer, tumor growth, poor prognosis, aggressive cancer subtype 
FNBP1L	gene symbol: FNBP1L. Functionality: protein binding, lipid binding, cadherin binding, gtpase binding, cilium assembly, vesicle budding, autophagy, signal transduction, membrane invagination, vesicle organization, transport, filopodium assembly, clathrin-dependent endocytosis, plasma membrane tubulation. Phenotype: contributes to her2-positive breast cancer via altered signal transduction and cytoskeletal dynamics 
JTB	gene symbol: JTB. Functionality: protein kinase binding, cell cycle regulation, cytokinesis, apoptosis, cell proliferation, kinase activity regulation. Phenotype: her2-positive breast cancer 
NBL1	gene symbol: NBL1. Functionality: protein binding, morphogen activity, bmp binding, identical protein binding, signal transduction, receptor ligand activity. Phenotype: nervous system development, negative regulation of bmp signaling, neuron differentiation, dorsal identity determination, neuron projection morphogenesis, negative regulation of monocyte chemotaxis. 
HM13	gene symbol: HER2. Functionality: protein binding, peptidase activity, ubiquitin ligase binding, aspartic endopeptidase activity, homodimerization, membrane protein proteolysis, signal peptide processing. Phenotype: her2-positive breast cancer, involved in embryonic development, oxidative stress response, retrograde protein transport. 
SLC2A4RG	gene symbol: SLC2A4RG. Functionality: dna-binding transcription factor activity, metal ion binding, regulation of transcription by rna polymerase ii. Phenotype: her2-positive breast cancer 
ROMO1	gene symbol: ROMO1. Functionality: protein binding, cation transport, protein transport, cell killing, response to ros, bacterial defense, mitochondrial insertion. Phenotype: increased ros levels, antimicrobial activity, mitochondrial dysfunction, cell senescence, immune response modulation. 
SERINC2	gene symbol: ERBB2. Functionality: receptor tyrosine kinase, mediates cell growth, differentiation, and survival. Phenotype: overexpression leads to her2-positive breast cancer, associated with aggressive tumor growth and poor prognosis. 
NDUFA11	gene symbol: ERBB2. Functionality: encodes her2/neu receptor tyrosine kinase, involved in cell proliferation and survival. Phenotype: overexpression leads to her2-positive breast cancer, associated with aggressive tumor growth. 
RHOC	gene symbol: RHOC. Functionality: protein binding, mitotic cytokinesis, signal transduction, regulation of cell migration, nf-kappab signaling, actin cytoskeleton organization, gtp binding, kinase binding, lipase activity regulation. Phenotype: her2-positive breast cancer, enhanced cell migration, cell spreading, wound healing, muscle satellite cell migration, stress fiber assembly, apical junction formation. 
TXNIP	gene symbol: TXNIP. Functionality: enables enzyme inhibitor activity, protein binding, ubiquitin protein ligase binding; involved in negative regulation of transcription by rna polymerase ii, protein import into nucleus, inflammatory response, response to oxidative stress and various stimuli, regulation of cell proliferation, positive regulation of apoptosis, pdgf receptor signaling, negative regulation of cell division, protein transport. Phenotype: associated with cellular response to tumor cells, oxidized ldl, estradiol and progesterone stimuli, keratinocyte differentiation, response to glucose, calcium ion, hydrogen peroxide, located in cytoplasm and cytosol. 
TYMP	gene symbol: TYMP. Functionality: thymidine phosphorylase activity, protein binding, growth factor activity, mitochondrial genome maintenance, angiogenesis, pyrimidine metabolic process, chemotaxis, signal transduction, cell differentiation, myelination regulation, nerve impulse regulation, gastric motility regulation. Phenotype: her2-positive breast cancer involvement, angiogenesis promotion, mitochondrial function alteration, tumor growth facilitation, potential impact on cancer metastasis. 
NACA	gene symbol: NACA. Functionality: dna binding, transcription coactivator, protein binding, translation, protein transport, unfolded protein binding, protein targeting. Phenotype: negative regulation of transcription, cardiac ventricle development, skeletal muscle tissue regeneration, positive regulation of cell proliferation, heart morphogenesis, wound healing. 
HSP90B1	gene symbol: HSP90B1. Functionality: protein folding, atp binding, rna binding, protein transport, chaperone activity, calcium ion binding, protein phosphatase inhibition, low-density lipoprotein receptor binding, atp-dependent protein folding, erad pathway, protein complex formation. Phenotype: her2-positive breast cancer, endoplasmic reticulum stress response, negative regulation of apoptosis, cellular response to hypoxia, cellular response to atp, actin rod assembly, sequestration of calcium ions 
SNRPB	gene symbol: SNRPB. Functionality: rna binding, protein binding, telomerase rna binding, histone pre-mrna dcp binding, snrnp binding, spliceosomal snrnp assembly, mrna splicing, spliceosome, 7-methylguanosine cap hypermethylation, u2-type prespliceosome assembly. Phenotype: her2-positive breast cancer association, altered rna splicing, potential impact on telomerase activity, nuclear and cytoplasmic localization 
PFKL	gene symbol: HER2. Functionality: receptor tyrosine kinase activity, dimerization, signal transduction, cell proliferation. Phenotype: breast cancer, aggressive, rapid tumor growth, poor prognosis. 
VCP	gene symbol: VCP. Functionality: dna repair, ubiquitination, chromatin remodeling, atp binding, protein transport, ubiquitin ligase binding, protein degradation, autophagy, stress response, apoptosis regulation. Phenotype: her2-positive breast cancer, cellular stress response, protein quality control, chromatin interaction, mitochondrial regulation, endoplasmic reticulum stress response 
ERGIC1	gene symbol: HER2. Functionality: receptor tyrosine kinase involved in cell growth and differentiation. Phenotype: overexpression leads to her2-positive breast cancer, affecting cell proliferation. 
NUCKS1	gene symbol: NUCKS1. Functionality: chromatin binding, dna/rna binding, transcription coactivator, dna repair, glucose homeostasis, dna replication regulation, chromatin organization, gene conversion, interstrand cross-link repair, viral transcription regulation, insulin signaling regulation, cellular response to x-ray. Phenotype: involvement in her2-positive breast cancer with roles in cancer cell survival, proliferation, and response to treatments. 
PSMD8	gene symbol: PSMD8. Functionality: enables protein binding, involved in ubiquitin-dependent protein catabolism, part of proteasome complex and regulatory particle. Phenotype: associated with her2-positive breast cancer, impacts protein degradation pathways in nucleus and cytosol. 
CALM2	gene symbol: HER2. Functionality: calcium-mediated signaling, adenylate cyclase activator, protein kinase binding, cardiac muscle contraction regulation. Phenotype: her2-positive breast cancer, enhanced cell proliferation, altered heart rate regulation 
AP2S1	gene symbol: AP2S1. Functionality: clathrin adaptor activity, protein binding, intracellular transport, vesicle transport, endocytosis regulation, clathrin coat assembly, synaptic vesicle endocytosis, clathrin-dependent endocytosis, receptor internalization. Phenotype: altered intracellular transport and endocytosis, potential impact on her2-positive breast cancer progression 
DBI	gene symbol: DBI. Functionality: protein binding, receptor binding, acyl-coa binding, phosphatidylcholine remodeling, regulation of protein lipidation and coa-transferase activity, phospholipid transport. Phenotype: linked to her2-positive breast cancer, influences lipid metabolism, impacts cellular processes in endoplasmic reticulum, golgi, and extracellular exosomes 
C4orf48	gene symbol: C4orf48. Functionality: unknown role in cellular processes; potential involvement in signaling pathways. Phenotype: not directly linked to her2-positive breast cancer; further research required. 
SDF4	gene symbol: ERBB2. Functionality: receptor tyrosine kinase, signal transduction, cell proliferation. Phenotype: her2-positive breast cancer, aggressive tumor growth, poor prognosis. 
TPI1	gene symbol: ERBB2. Functionality: encodes tyrosine kinase receptor; involved in cell growth, differentiation, repair. Phenotype: overexpression leads to her2-positive breast cancer; aggressive tumor growth; poor prognosis. 
